http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2034571-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9777ff67e985cc3cf5a45c449feda918 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9be04d501e2f50660c8e05c6aef2a1cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afaaa5ab719339d0998e01c6f8d9cd89 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2128c1d1a8ee2970908b0062bb8d0221 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f4ac611e5891fcf83c1d36f73f6ee7d6 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 |
filingDate | 1992-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1995-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6090ae83d01d19819d2ddf849544b53a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_548d153cfb5dfd57db8423ad1bd32fd4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5191147d04db43641bdab6afa56e9e8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45df5e536770284edbc6e6c46862d4a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccd348ebcfc80b5aa25f5a9cca174dbc |
publicationDate | 1995-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2034571-C1 |
titleOfInvention | Biologically active preparation for minks |
abstract | FIELD: veterinary. SUBSTANCE: preparation has, wt.-%: proteins 3-50; amino acids 1.6-5; fatty acids 0.1-15; sugars 2.5-25; ascorbic acid 0.6-10; water 1-8, and mineral acid salts - the rest. Preparation is prepared by cultivation of virus- and/or nonvirus-induced lymphoid cells of chicken following by filtration. Then one part of filtrate is lyophilized, dissolved in buffer solution and added (1:10) to the aerosol OT solution, then fatty acids (10-1000 mcg) and sugars (5-20 mg) were added and mixed with 2-5-fold acetone solution. Prepared precipitate is dissolved in saline solution, mixed with the second part of filtrate and lyophilized. Preparation with activity 10 000 U is administrated 2-3-fold by peroral, intranasal or parenteral route at the dose 0.5-1 ml for prophylaxis, and with activity 1 000 000 U 3-4-fold at the dose 1 ml, twice per a day for treatment. EFFECT: enhanced effectiveness of preparation. 6 cl, 1 tbl |
priorityDate | 1992-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 110.